Evaluating only Helo Saúde’s profile at its peak — without knowing the outcome — the model ranked Regulation as the #1 likely cause. That’s exactly how it died.
Key Events Timeline
FOUNDING
Helo Saúde founded in São Paulo during COVID-19 to offer affordable subscription teletherapy to Brazilian consumers.
FUNDING
Raised R$18M seed from Valor Capital Group; grew to 40,000 paying subscribers within 12 months.
REGULATORY ACTION
ANS mandated private health plans cover teletherapy; 35% of Helo subscribers cancelled to use insurer-covered alternatives.
SHUTDOWN
Platform shut down after subscriber base fell below 20,000 and therapist cost structure made unit economics unviable.
Full Analysis
Free · no account needed
Documented cause
Helo Saúde was a São Paulo-based mental health platform offering therapy sessions via subscription for R$149/month, founded during the COVID-19 pandemic. It raised R$18M in a seed round from Valor Capital Group in 2021. The platform grew to 40,000 subscribers but faced therapist supply constraints — licensed psychologists demanded 60% of session fees, crushing margins. Brazil's ANS (health insurance regulator) announced in 2022 that private health plans must cover teletherapy, causing subscribers to cancel Helo and migrate to insurer-covered alternatives. The company shut down in April 2023.
Lesson
“Healthcare subscription businesses must monitor regulatory mandates that could force their paying users into free coverage.”